Luis Rubio

1.9k total citations
42 papers, 819 citations indexed

About

Luis Rubio is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Luis Rubio has authored 42 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Luis Rubio's work include Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Polyomavirus and related diseases (5 papers). Luis Rubio is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Polyomavirus and related diseases (5 papers). Luis Rubio collaborates with scholars based in Spain, United States and Austria. Luis Rubio's co-authors include José Antonio López‐Guerrero, Antonio Fernández‐Serra, Zaida García‐Casado, J. Rubio‐Briones, Ana Calatrava, M. Backhaus, Irene Casanova‐Salas, José L. Domínguez-Escrig, J. Casanova and Eduardo Nagore and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and The Journal of Urology.

In The Last Decade

Luis Rubio

41 papers receiving 809 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luis Rubio Spain 18 296 295 260 202 108 42 819
Shenghua Mao United States 15 149 0.5× 190 0.6× 69 0.3× 191 0.9× 172 1.6× 38 790
Amel Mézlini Tunisia 18 195 0.7× 136 0.5× 214 0.8× 421 2.1× 30 0.3× 125 1.0k
Chirayu Auewarakul Thailand 18 237 0.8× 110 0.4× 94 0.4× 151 0.7× 51 0.5× 63 1.0k
Yara Abdou United States 13 90 0.3× 113 0.4× 101 0.4× 415 2.1× 99 0.9× 64 626
Abdellatif Benider Morocco 16 134 0.5× 106 0.4× 130 0.5× 498 2.5× 41 0.4× 102 906
Eliano Cascardi Italy 15 196 0.7× 122 0.4× 119 0.5× 245 1.2× 24 0.2× 70 736
P. Fernandez South Africa 15 164 0.6× 278 0.9× 125 0.5× 175 0.9× 32 0.3× 45 797
Richard de Boer Australia 15 333 1.1× 321 1.1× 159 0.6× 1.2k 6.0× 78 0.7× 42 1.5k
John T. Cole United States 10 110 0.4× 108 0.4× 86 0.3× 189 0.9× 33 0.3× 25 613
Emirena Garrafa Italy 15 142 0.5× 64 0.2× 56 0.2× 197 1.0× 108 1.0× 34 669

Countries citing papers authored by Luis Rubio

Since Specialization
Citations

This map shows the geographic impact of Luis Rubio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Rubio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Rubio more than expected).

Fields of papers citing papers by Luis Rubio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Rubio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Rubio. The network helps show where Luis Rubio may publish in the future.

Co-authorship network of co-authors of Luis Rubio

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Rubio. A scholar is included among the top collaborators of Luis Rubio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Rubio. Luis Rubio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laurie, Matthew T., Jamin Liu, Sara Sunshine, et al.. (2022). SARS-CoV-2 Variant Exposures Elicit Antibody Responses With Differential Cross-Neutralization of Established and Emerging Strains Including Delta and Omicron. The Journal of Infectious Diseases. 225(11). 1909–1914. 29 indexed citations
2.
3.
Llombart, B., C. Serra‐Guillén, Luis Rubio, et al.. (2017). Subcutaneous dermatofibrosarcoma protuberans, a rare subtype with predilection for the head: A retrospective series of 18 cases. Journal of the American Academy of Dermatology. 77(3). 503–511.e1. 27 indexed citations
4.
Rubio‐Briones, J., J. Casanova, Fernando Martínez, et al.. (2017). PCA3 como biomarcador de segunda línea en un programa de screening oportunista prospectivo, aleatorizado y controlado. Actas Urológicas Españolas. 41(5). 300–308. 8 indexed citations
5.
Rubio‐Briones, J., Ángel Borque‐Fernando, Luis Esteban, et al.. (2015). Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy. BMC Cancer. 15(1). 633–633. 13 indexed citations
6.
Requena, Celia, Virginia Sanz, Eduardo Nagore, et al.. (2015). BAP1‐deficient and VE1‐negative atypical Spitz tumor. Journal of Cutaneous Pathology. 42(8). 564–567. 13 indexed citations
7.
Casanova‐Salas, Irene, J. Rubio‐Briones, Ana Calatrava, et al.. (2014). Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer. European Journal of Cancer. 50(17). 2994–3002. 40 indexed citations
8.
Machado, Isidro, Julia Cruz, Javier Lavernia, et al.. (2013). Superficial EWSR1-negative undifferentiated small round cell sarcoma with CIC/DUX4 gene fusion: a new variant of Ewing-like tumors with locoregional lymph node metastasis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 463(6). 837–842. 45 indexed citations
9.
Rubio‐Briones, J., J. Casanova, R. Dumont, et al.. (2013). Optimización de un programa de cribado oportunista de cáncer de próstata; ensayo aleatorizado prospectivo del papel del PSA y del PCA3 en uso secuencial. Actas Urológicas Españolas. 38(4). 217–223. 9 indexed citations
10.
Botella‐Estrada, Rafael, Vincent Soriano, Luis Rubio, & Eduardo Nagore. (2012). Mutaciones en KIT en una serie de melanomas y repercusiones en el tratamiento con imatinib. Actas Dermo-Sifiliográficas. 103(9). 838–840. 6 indexed citations
11.
Requena, Celia, Luis Rubio, V. Través, et al.. (2012). Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma. Histopathology. 61(5). 899–909. 36 indexed citations
12.
Rubio‐Briones, J., Ana Calatrava, Antonio Fernández‐Serra, et al.. (2011). Expresión inmunohistoquímica de la densidad microvascular y de la anhidrasa carbónica IX en carcinoma renal. Relación con el tipo histológico y con la progresión tumoral. Actas Urológicas Españolas. 35(2). 80–86. 3 indexed citations
13.
García‐Casado, Zaida, et al.. (2011). A de novo complete BRCA1 gene deletion identified in a Spanish woman with early bilateral breast cancer. BMC Medical Genetics. 12(1). 134–134. 24 indexed citations
14.
Rubio‐Briones, J., Antonio Fernández‐Serra, Luis Rubio, et al.. (2011). Resultados del uso expandido del PCA3 score en una población española con sospecha de cáncer de próstata. Actas Urológicas Españolas. 35(10). 589–596. 21 indexed citations
15.
Rubio, Luis, Joel Pinczewski, Cinthia B. Drachenberg, Francisco Vera‐Sempere, & Yuqi Zhao. (2010). A Multiplex Real-time PCR Method for Quantification of BK and JC Polyomaviruses in Renal Transplant Patients. Diagnostic Molecular Pathology. 19(2). 105–111. 5 indexed citations
16.
Rubio‐Briones, J., Antonio Fernández‐Serra, Ana Calatrava, et al.. (2010). Clinical Implications of TMPRSS2-ERG Gene Fusion Expression in Patients With Prostate Cancer Treated With Radical Prostatectomy. The Journal of Urology. 183(5). 2054–2061. 37 indexed citations
17.
Vera‐Sempere, Francisco, Luis Rubio, Á. García-Muñoz, et al.. (2006). Renal Donor Implication in the Origin of BK Infection: Analysis of Genomic Viral Subtypes. Transplantation Proceedings. 38(8). 2378–2381. 20 indexed citations
18.
Vera‐Sempere, Francisco, Luis Rubio, Ana Maria Garcı́a, et al.. (2006). PCR assays for the early detection of BKV infection in 125 Spanish kidney transplant patients. Clinical Transplantation. 20(6). 706–711. 2 indexed citations
19.
Rubio, Luis, et al.. (2005). LT, VP1 and TCR-BKV sequence analysis in a patient with post-transplant BKV nephropathy associated with EBV-related PTLD. Pediatric Nephrology. 20(10). 1506–1509. 4 indexed citations
20.
Rubio, Luis, et al.. (2003). Comparación de phadiatop y pruebas cutáneas en 130 pacientes con sospecha de rinitis alérgica. Acta Otorrinolaringológica Española. 54(8). 540–546. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shenghua Mao Breakdown of academic impact, for papers by Amel Mézlini Breakdown of academic impact, for papers by Chirayu Auewarakul Breakdown of academic impact, for papers by Yara Abdou Breakdown of academic impact, for papers by Abdellatif Benider Breakdown of academic impact, for papers by Eliano Cascardi Breakdown of academic impact, for papers by P. Fernandez Breakdown of academic impact, for papers by Richard de Boer Breakdown of academic impact, for papers by John T. Cole Breakdown of academic impact, for papers by Emirena Garrafa
Rankless by CCL
2026